Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages

  Weiner, Alexandra S ^a,b   Boyarskikh, Uljana A ^a   Voronina, Elena N ^a   Selezneva, Inna A ^c   Sinkina, Tatiana V ^c   Lazarev, Alexandr F ^c   Petrova, Valentina D ^c   Filipenko, Maxim L ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Breast cancer; Folate metabolizing genes; Meta analysis; Polymorphism; SNP

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; ASIA; BREAST CANCER; CANCER RISK; CELL HETEROGENEITY; CONTROLLED STUDY; EUROPE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; BREAST NEOPLASMS; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84858798306     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.11.010     Document Type: Article

References (47)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
2. Davydov M.I, Aksel E.M. Cancer statistics in Russia and CIS in 2007. J N N Blokhin Russian Cancer Res Center RAMS 2009.
3. Oldenburg R.A., Meijers-Heijboer H., Cornelisse C.J., Devilee P. Genetic susceptibility for breast cancer: how many more genes to be found?. Crit Rev Oncol Hematol 2007, 63(2):125-149.
4. Choi S.W., Mason J.B. Folate and carcinogenesis: an integrated scheme. J Nutr 2000, 130(2):129-132.
5. Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry 2005, 70(5):651-669.
6. Weiner A.S., Boyarskih U.A., Voronina E.N., Seleznevaet I.A., Sinkina T.V., Lazarev A.F., et al. Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR and C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in the West Siberian region of Russia. Mol Biol 2010, 44(5):720-727.
7. Konovalova V.N. Breast cancer and estrogen metabolism: a review. Russian J Human Reprod 2007, 5:15-20. [in Russian].
8. Ott N., Geddert H., Sarbia M. Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 2008, 134(3):405-410.
9. Linnebank M., Schmidt S., Kolsch H., Linnebank A., Heun R., Schmidt-Wolf I.G., et al. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 2004, 90(10):1969-1971.
10. Relton C.L., Wilding C.S., Pearce M.S., Laffling A.J., Jonas P.A., Lynch S.A., et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 2004, 41(4):256-260.
11. Zhang G., Dai C. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res 2001, 104(3):187-195.
12. Franco R.F., Elion J., Lavinha J., Krishnamoorthy R., Tavella M.H., Zago M.A. Heterogeneous ethnic distribution of the 844ins68 in the cystathionine beta-synthase gene. Hum Hered 1998, 48(6):338-342.
13. Chen L.H., Liu M.L., Hwang H.Y., Chen L.S., Korenberg J., Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem 1997, 272(6):3628-3634.
14. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998, 62(5):1044-1051.
15. van der Put N.M., van der Molen E.F., Kluijtmans L.A., Heil S.G., Trijbels J.M., Eskes T.K., et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med 1997, 90(8):511-517.
16. Galdieri L.C., Arrieta S.R., Silva C.M., Pedra C.A., D'Almeida V. Homocysteine concentrations and molecular analysis in patients with congenital heart defects. Arch Med Res 2007, 38(2):212-218.
17. Siva A., De Lange M., Clayton D., Monteith S., Spector T., Brown M.J. The heritability of plasma homocysteine, and the influence of genetic variation in the homocysteine methylation pathway. Q J Med 2007, 100(8):495-499.
18. Klerk M., Lievers K.J., Kluijtmans L.A., Blom H.J., den Heijer M., Schouten E.G., et al. The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res 2003, 110(2-3):87-91.
19. Fillon-Emery N., Chango A., Mircher C., Barbé F., Bléhaut H., Herbeth B., et al. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms. Am J Clin Nutr 2004, 80(6):1551-1557.
20. Morita H., Kurihara H., Sugiyama T., Hamada C., Kurihara Y., Shindo T., et al. Polymorphism of the methionine synthase gene: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol 1999, 19(2):298-302.
21. Jacques P.F., Bostom A.G., Selhub J., Rich S., Ellison R.C., Eckfeldt J.H., et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI family heart study. Atherosclerosis 2003, 166(1):49-55.
22. Bosco P., Guéant-Rodriguez R.M., Anello G., Barone C., Namour F., Caraci F., et al. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003, 121A(3):219-224.
23. Huang L., Song X.M., Zhu W.L., Li Y. Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects. Biomed Environ Sci 2008, 21(6):514-520.
24. Ma J., Stampfer M.J., Christensen B., Giovannucci E., Hunter D.J., Chen J., et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999, 8(9):825-829.
25. Harmon D.L., Shields D.C., Woodside J.V., McMaster D., Yarnell J.W., Young I.S., et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999, 17(4):298-309.
26. Chen J., Stampfer M.J., Ma J., Selhub J., Malinow M.R., Hennekens C.H., et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001, 154(3):667-672.
27. Tsai M.Y., Bignell M., Yang F., Welge B.G., Graham K.J., Hanson N.Q. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000, 149(1):131-137.
28. Fredriksen A., Meyer K., Ueland P.M., Vollset S.E., Grotmol T., Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007, 28(9):856-865.
29. Kim O.J., Hong S.P., Ahn J.Y., Hong S.H., Hwang T.S., Kim S.O., et al. Influence of combined methionine synthase (MTR 2756A>G) and methylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke. Yonsei Med J 2007, 48(2):201-209.
30. Olteanu H., Munson T., Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002, 41(45):13378-13385.
31. Gaughan D.J., Kluijtmans L.A., Barbaux S., McMaster D., Young I.S., Yarnell J.W., et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001, 157(2):451-456.
32. Geisel J., Zimbelmann I., Schorr H., Knapp J.P., Bodis M., Hübner U., et al. Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 2001, 39(8):698-704.
33. O'Leary V.B., Parle-McDermott A., Molloy A.M., Kirke P.N., Johnson Z., Conley M., et al. M.T.R.R. and MTHFR polymorphism: link to Down syndrome?. Am J Med Genet 2002, 107(2):151-155.
34. Lu M., Wang F., Qiu J. Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects. Breast Cancer Res Treat 2010, 123(1):213-217.
35. Lissowska J., Gaudet M.M., Brinton L.A., Chanock S.J., Peplonska B., Welch R., et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 2007, 120(12):2696-2703.
36. Platek M.E., Shields P.G., Marian C., McCann S.E., Bonner M.R., Nie J., et al. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18(9):2453-2459.
37. Ma E., Iwasaki M., Junko I., Hamada G.S., Nishimoto I.N., Carvalho S.M., et al. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 2009, 9:122.
38. Stevens V.L., McCullough M.L., Pavluck A.L., Talbot J.T., Feigelson H.S., Thun M.J., et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 2007, 16(6):1140-1147.
39. Nazarenko M.S., Puzyrev V.P., Kazantseva O.M., Strakevich E.E., Malinovskaya E.A., Litvyakov N.V., et al. Folate-metabolizing genes and breast cancer risk. Meditsinskaya genetika 2009, 1:31-37. [in Russian].
40. Suzuki T., Matsuo K., Hirose K., Hiraki A., Kawase T., Watanabe M., et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008, 29(2):356-362.
41. Shrubsole M.J., Gao Y.T., Cai Q., Shu X.O., Dai Q., Jin F., et al. MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15(3):586-588.
42. Ma E., Iwasaki M., Kobayashi M., Kasuga Y., Yokoyama S., Onuma H., et al. Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer 2009, 61(4):446-456.
43. Justenhoven C., Hamann U., Pierl C.B., Rabstein S., Pesch B., Harth V., et al. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev 2005, 14(12):3015-3018.
44. Kotsopoulos J., Zhang W.W., Zhang S., McCready D., Trudeau M., Zhang P., et al. Polymorphisms in folate-metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 2008, 112(3):585-593.
45. Xu X., Gammon M.D., Zhang H., Wetmur J.G., Rao M., Teitelbaum S.L., et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007, 28(7):1504-1509.
46. Yu C.P., Wu M.H., Chou Y.C., Yang T., You S.L., Chen C.J., et al. Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Anticancer Res 2007, 27(3B):1727-1732.
47. Sangrajrang S., Sato Y., Sakamoto H., Ohnami S., Khuhaprema T., Yoshida T. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat 2010, 1239(3):885-893.